BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 34667157)

  • 1. Signaling pathways in the regulation of cytokine release syndrome in human diseases and intervention therapy.
    Li X; Shao M; Zeng X; Qian P; Huang H
    Signal Transduct Target Ther; 2021 Oct; 6(1):367. PubMed ID: 34667157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients.
    Olbei M; Hautefort I; Modos D; Treveil A; Poletti M; Gul L; Shannon-Lowe CD; Korcsmaros T
    Front Immunol; 2021; 12():629193. PubMed ID: 33732251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characterization and risk factors associated with cytokine release syndrome induced by COVID-19 and chimeric antigen receptor T-cell therapy.
    Hong R; Zhao H; Wang Y; Chen Y; Cai H; Hu Y; Wei G; Huang H
    Bone Marrow Transplant; 2021 Mar; 56(3):570-580. PubMed ID: 32943758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of cytokine release syndrome and neurotoxicity in chimeric antigen receptor (CAR) T cell therapy.
    Acharya UH; Dhawale T; Yun S; Jacobson CA; Chavez JC; Ramos JD; Appelbaum J; Maloney DG
    Expert Rev Hematol; 2019 Mar; 12(3):195-205. PubMed ID: 30793644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shared inflammatory pathways and therapeutic strategies in COVID-19 and cancer immunotherapy.
    Iovino L; Thur LA; Gnjatic S; Chapuis A; Milano F; Hill JA
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33986127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunologic aspects of cytokine release syndrome and graft versus host disease following CAR T cell therapy.
    Mansouri V; Yazdanpanah N; Rezaei N
    Int Rev Immunol; 2022; 41(6):649-668. PubMed ID: 34607523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interindividual immunogenic variants: Susceptibility to coronavirus, respiratory syncytial virus and influenza virus.
    Darbeheshti F; Mahdiannasser M; Uhal BD; Ogino S; Gupta S; Rezaei N
    Rev Med Virol; 2021 Nov; 31(6):e2234. PubMed ID: 33724604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive role of endothelial cell activation in cytokine release syndrome after chimeric antigen receptor T cell therapy for acute lymphoblastic leukaemia.
    Hong F; Shi M; Cao J; Wang Y; Gong Y; Gao H; Li Z; Zheng J; Zeng L; He A; Xu K
    J Cell Mol Med; 2021 Dec; 25(24):11063-11074. PubMed ID: 34734474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine Release Syndrome Biology and Management.
    Cobb DA; Lee DW
    Cancer J; 2021 Mar-Apr 01; 27(2):119-125. PubMed ID: 33750071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Cytokine Storm to Manage Patients with COVID-19: A Mini-Review.
    Roshanravan N; Seif F; Ostadrahimi A; Pouraghaei M; Ghaffari S
    Arch Med Res; 2020 Oct; 51(7):608-612. PubMed ID: 32682575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza infection, SARS, MERS and COVID-19: Cytokine storm - The common denominator and the lessons to be learned.
    Ryabkova VA; Churilov LP; Shoenfeld Y
    Clin Immunol; 2021 Feb; 223():108652. PubMed ID: 33333256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case Report: Local Cytokine Release Syndrome in an Acute Lymphoblastic Leukemia Patient After Treatment With Chimeric Antigen Receptor T-Cell Therapy: A Possible Model, Literature Review and Perspective.
    Luan C; Zhou J; Wang H; Ma X; Long Z; Cheng X; Chen X; Huang Z; Zhang D; Xia R; Ge J
    Front Immunol; 2021; 12():707191. PubMed ID: 34349766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome.
    Kang S; Tanaka T; Inoue H; Ono C; Hashimoto S; Kioi Y; Matsumoto H; Matsuura H; Matsubara T; Shimizu K; Ogura H; Matsuura Y; Kishimoto T
    Proc Natl Acad Sci U S A; 2020 Sep; 117(36):22351-22356. PubMed ID: 32826331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and Risk Factors of Cytokine Release Syndrome in Chimeric Antigen Receptor T Cell Treatment.
    Yan Z; Zhang H; Cao J; Zhang C; Liu H; Huang H; Cheng H; Qiao J; Wang Y; Wang Y; Gao L; Shi M; Sang W; Zhu F; Li D; Sun H; Wu Q; Qi Y; Li H; Wang X; Li Z; Liu H; Zheng J; Qian W; Zhang X; Xu K
    Front Immunol; 2021; 12():611366. PubMed ID: 33708205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 in patients with cancer: Risks and precautions.
    Razavi A; Hamblin MR; Rezaei N
    Am J Emerg Med; 2021 Oct; 48():357-360. PubMed ID: 33546958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management Principles Associated With Cytokine Release Syndrome.
    Baer B; Dudley CV; Simons RM
    Semin Oncol Nurs; 2019 Oct; 35(5):150931. PubMed ID: 31477411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine release syndrome after allogeneic stem cell transplantation with posttransplant cyclophosphamide.
    Solán L; Landete E; Bailén R; Dorado N; Oarbeascoa G; Anguita J; Díez-Martín JL; Kwon M
    Hematol Oncol; 2020 Oct; 38(4):597-603. PubMed ID: 32592410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Pathophysiological Mechanisms Underlying Multiple Organ Dysfunction in Cytokine Release Syndrome.
    Chen P; Tang Y; He W; Yang R; Lan Z; Chen R; Zhang P
    Mediators Inflamm; 2022; 2022():7137900. PubMed ID: 35431655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine Release Syndrome during Antithymocyte Globulin/Anti-T Lymphocyte Globulin Serotherapy for Graft-versus-Host Disease Prophylaxis before Allogeneic Hematopoietic Stem Cell Transplantation: Incidence and Early Clinical Impact According to American Society of Transplantation and Cellular Therapy Grading Criteria.
    Knaus HA; Rottner T; Baumann CK; Cserna J; Mitterbauer M; Schulenburg A; Rabitsch W; Wohlfarth P
    Transplant Cell Ther; 2022 May; 28(5):260.e1-260.e9. PubMed ID: 35217212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine Release Syndrome Associated with T-Cell-Based Therapies for Hematological Malignancies: Pathophysiology, Clinical Presentation, and Treatment.
    Cosenza M; Sacchi S; Pozzi S
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.